[图书][B] Tumors of the thyroid and parathyroid glands

J Rosai, RA DeLellis, ML Carcangiu, WJ Frabel… - 2014 - cris.unibo.it
In the years since the publication of the Third Series AFIP Fascicles on the thyroid and
parathyroid glands, awareness of the remarkable morphologic diversity of thyroid carcinoma …

[HTML][HTML] The treatment of well-differentiated thyroid carcinoma

R Paschke, T Lincke, SP Müller… - Deutsches Ärzteblatt …, 2015 - ncbi.nlm.nih.gov
Background Recent decades have seen a rise in the incidence of well-differentiated (mainly
papillary) thyroid carcinoma around the world. In Germany, the age-adjusted incidence of …

Nanomaterials: a promising multimodal theranostics platform for thyroid cancer

L Li, Z Wang, H Guo, Q Lin - Journal of Materials Chemistry B, 2023 - pubs.rsc.org
Thyroid cancer is the most prevalent malignant neoplasm of the cervical region and
endocrine system, characterized by a discernible upward trend in incidence over recent …

[HTML][HTML] Recent advances in managing differentiated thyroid cancer

L Lamartina, G Grani, C Durante, S Filetti - F1000Research, 2018 - ncbi.nlm.nih.gov
The main clinical challenge in the management of thyroid cancer is to avoid over-treatment
and over-diagnosis in patients with lower-risk disease while promptly identifying those …

Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers

SR Rajjoub, H Yan, NA Calcatera, K Kuchta… - Surgery, 2018 - Elsevier
Background Histologic subtypes of papillary thyroid cancer affect prognosis. The objective of
this study was to examine whether survival is affected by extent of surgery for conventional …

The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering …

IJ Nixon, I Ganly, SG Patel, FL Palmer, MM Di Lorenzo… - Thyroid, 2013 - liebertpub.com
Background: The American Thyroid Association guidelines recommend the routine use of
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …

Association of TERT promoter mutation, but not BRAF mutation, with increased mortality in PTC

JR George, YC Henderson, MD Williams… - The Journal of …, 2015 - academic.oup.com
Context: Papillary thyroid carcinoma (PTC) carrying the BRAF mutation has been reported to
be associated with high recurrence and potentially increased mortality. PTC carrying the …

[PDF][PDF] 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer

EK Alexander, KC Bible, GM Doherty, SJ Mandel… - …, 2016 - medi-guide.meditool.cn
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Extent of surgery for low-risk differentiated thyroid cancer

AD McDow, SC Pitt - Surgical Clinics, 2019 - surgical.theclinics.com
Thyroid cancer is the fifth most common cancer in women and represents 3.1% of all new
cancer cases in the United States. 1, 2 Currently, an estimated 53,990 new cases of thyroid …

Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit

WT Shen, L Ogawa, D Ruan, I Suh, QY Duh, OH Clark - Surgery, 2010 - Elsevier
BACKGROUND: The role of routine prophylactic central-neck lymph node dissection
(CLND) for papillary thyroid cancer (PTC) remains controversial. We perform CLND for PTC …